Overview
CVRx develops the Barostim system, a neuromodulation device that activates baroreceptors to treat heart failure and hypertension. The company's technology delivers electrical stimulation to the carotid sinuses to improve cardiovascular function and patient outcomes.
More in Neurotechnology
Latest industry news
Synchron Pauses Brain Implant Trials After Performance Issues Surface
2026-11-12 · Industry
Generative AI Is Closing the Gap on Brain-Computer Interface Accuracy and Resolution
2026-11-11 · Research
Spiking Neural Networks Emerge as a Viable Shield Against Signal Noise in Brain-Computer Interfaces
2026-11-10 · Research
China's Brain-Reading Device Hits 94% Mind-Typing Accuracy Over a Full Day of Use
2026-11-09 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →